Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults and ...

Shares of Eli Lilly & Co. LLY advanced 1.11% to $915.04 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 and ...

As a part of this expansion, Lilly will create another 150 jobs for highly skilled workers in Limerick, bringing its total ...

Eli Lilly has partnered with the AI-driven drug discovery startup company, Genetic Leap ... you agree to receive communications from us regarding website updates and other offerings that may ...

We recently compiled a list of the 7 Best Big Company Stocks to Buy Now. In this article, we are going to take a look at ...

Defining ESG can sometimes be straightforward: it’s a finance and investing approach centered on managing risks related to ...

Good morning. Eli Lilly and Company has promoted longtime executive Lucas Montarce to the role of CFO. The move is similar to the career path of his predecessor, Anat Ashkenazi, who also spent two ...

On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use ... will be available in the next few weeks, the company said. Eczema, also known as atopic dermatitis ...

In the,Healthcare sector,, Eli Lilly is making headlines with a new development that could resolve one of the major issues ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other Jim Cramer’s best stocks for investors. In a recent episode of Mad Money, Jim Cramer ...